Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-[(1S,2S,5S)-5-(hydroxymethyl)-6,8,9-trimethyl-3-oxabicyclo[3.3.1]non-7-en-2-yl]phenol
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
4-[(1S,2S,5S)-5-(hydroxymethyl)-6,8,9-trimethyl-3-oxabicyclo[3.3.1]non-7-en-2-yL]phenol is a synthetic small molecule with the molecular formula C18H24O3 and a molecular weight of approximately 288.38 g/mol[4][7]. It is classified as a non-polymer compound and has been identified in chemical databases such as DrugBank (DB07195), PubChem (CID: 46937048), ChemSpider (ID: 5257033), and ZINC15 as a pharmaceutical agent and potential endocrine-disrupting compound[1][4][7]. Structural studies show it can bind to nuclear hormone receptors—specifically the estrogen receptor alpha ligand-binding domain—suggesting it may act as an estrogen receptor modulator or mimic in biological systems[1][7]. However, there are no approved medical indications or clinical trials for this compound to date; its pharmacological activity remains primarily characterized by its interaction with nuclear hormone receptors.
- Other names
- 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL
02
Targets
ESR1 (ERα)
Beyond the preview
Go deeper on 4-[(1S,2S,5S)-5-(hydroxymethyl)-6,8,9-trimethyl-3-oxabicyclo[3.3.1]non-7-en-2-yl]phenol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-[(1S,2S,5S)-5-(hydroxymethyl)-6,8,9-trimethyl-3-oxabicyclo[3.3.1]non-7-en-2-yl]phenol.